-1.1 C
Ottawa
Thursday, April 3, 2025

Cancer-treatment developer CG Oncology files for IPO

Date:

Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission.

Thank you for reading this post, don't forget to subscribe!

The Irvine, Calif.-based biopharmaceutical company is developing a potential therapeutic for bladder-cancer patients who are unresponsive to immunotherapy Bacillus Calmette-Guerin treatment.

CG Oncology did not say how many shares it planned to offer or give an estimated price range. The company plans to use proceeds primarily for supporting operations.

The company has applied to list its shares on the Nasdaq Global Market under the ticker CGON.

Morgan Stanley, Goldman Sachs & Co., Cantor and Lifesci Capital are acting as the underwriters of the offering.

know more

Popular

More like this
Related

Investors are turning bearish on the U.S. dollar as Trump tariffs loom

Foreign currencies advertised in a window in Times Square,...

Europe’s pharma industry braces for tariffs as carve-out hopes fade

SEIZED OZEMPIC, WEGOVY AND OTHER WEIGHT LOSS DRUGS AT...

Locked in a trade balancing act with the U.S., the UK hopes it can escape some Trump tariffs

British Prime Minister Keir Starmer and U.S. President Donald...

Man Utd whinger tops list of Premier League’s overworked players

There are some tired bodies and weary minds around the Premier League at this time. Here, then, are the 10 Premier League outfield players to have racked up the most minutes this season. Goalkeepers don’t count, obviously, because they don’t get tired do they? But every minute played by everyone else in all competitions for